FUTURE AJANTA PHARMA Fundamental Report

SHARE PRICE

Get to know the company overview of AJANTPHARM - face value, book value, exchange symbol, 1 year & lifetime highs/lows, average volume, market cap, PE ratio, 1 month return, % promoter holding pledged before investing in AJANTPHARM

Current Price (Rs.) 933.30
Face Value (Rs.) 2
Book Value (Rs.) 257.18
52 Week High (Rs.) 1294.00 (07-Sep-18)
52 Week Low (Rs.) 873.40 (11-Jul-19)
Life Time high (Rs.) 2125.00 (04-Oct-16)
Life Time low (Rs.) 2.73 (28-Mar-03)
Exchange Symbol AJANTPHARM (NSE)
Average Daily Movement [ADM] 37.20
Average Volume [20 days](No. of shares) 195436
Market Cap (Rs. in Cr) 8143.49 (Cr)
1 Month Return (%) 1.15
P/E Ratio (x) 20.83
% of Promoter holding pledged 13.37

SHARE PRICE CHART

We recommend to use only Weekly and Monthly charts. Daily charts are also given which are used for exits.

We do not recommend daily/intraday minute hourly charts.

Why should you follow Weekly & Monthly levels - The major levels come from weekly and monthly charts which the FII, fund managers usually use for entry and profit booking.

AJANTA PHARMA, NSE, INDIA

FUTURE AJANTA PHARMA, NSE, INDIA

 

QUARTERLY RESULTS

Mar-19 Dec-18 Sep-18 Jun-18 Mar-18 Dec-17
Quarterly Quarterly Quarterly Quarterly Quarterly Quarterly
Source Of Info (AR = Annual Report, PR = Press Release)
Net Sales/Income from operations
Other Operating Income
Total Income From Operations
Increase/Decrease in Stocks
Consumption of Raw Materials
Purchase of Traded Goods
Employees Cost
Depreciation
Other Expenses
Total Expenditure
Operating Profit
Other Income
P/L Before Int., Excpt. Items & Tax
Interest
P/L Before Exceptional Items & Tax
P/L Before Tax
Tax
P/L After Tax from Ordinary Activities
PAT
Net Profit/(Loss) For the Period
Equity Share Capital
Reserves
Equity Dividend Rate (%)
EPS (Rs.) [After Extraordinary items]
EPS (Rs.) [Before Extraordinary items]
 

RATIO ANALYSIS

Among all the ratios these are the most important ratios to look before investing in a company.
Get the latest key Financial Ratios and the Ratio Analysis of to gauge the overall financial health of a company before investing.

Name Ratio Good/Not Good Description
Current Ratio (x) 2.83 > 2 is Good,
< 2 is Not Good
A liquidity ratio that measures a companys ability to pay short-term obligations. The higher the current ratio, the more capable the company is of paying its obligations.
Quick Ratio (x) 1.71 > 1 is Good,
< 1 is Not Good
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets
Dividend Yield (%) 0.96 > 1.5 is Good,
< 1.5 is Not Good
A financial ratio that shows how much a company pays out in dividends each year relative to its share price. Dividend yield is calculated as annual dividends per share divided by market price per share.
Interest Coverage Ratio (x) 506.47 > 2 is Good,
< 2 is Not Good
(For Banks & NBFC this is not Valid)
It is used to determine how easily a company can pay interest on outstanding debt. It is calculated by dividing a companys EBIT by the interest expenses.
Debt Equity Ratio (x) 0.02 < 2 is Good,
> 2 is Not Good
(For Banks & NBFC this is not Valid)
A measure of a companys financial leverage calculated by dividing its total liabilities by stockholders equity. The debt/equity ratio also depends on the industry in which the company operates.
Return On Asset (%) 15.40 > 5% is Good,
< 5% is Not Good
An indicator of how efficient management is at using its assets to generate earnings. Calculated by dividing a companys annual earnings by its total assets
Return On Equity (%) 17.24 > 18% is Good,
< 18% is Not Good
Also called Return on networth, it measures a companys profitability by revealing how much profit a company generates with the money shareholders have invested, it is calculated by dividing the net profit after tax by shareholder's fund For high growth companies you should expect a higher ROE.

For investors interested in FUTURE AJANTA PHARMA find all important information on FUTURE AJANTA PHARMA share price, peer comparison and analysis.

 

DIVIDEND

 

Get a glimpse into the dividend history-payout amount of AJANTPHARM, interim dividend and the latest dividend announcements by AJANTPHARM in the last 5 years.

# Announcement Date Ex-Date Amount Interim/Final
1 22-Oct-2018 09-Nov-2018 9.00 Interim
2 16-Mar-2017 23-Mar-2017 7.00 Interim
3 26-Oct-2016 07-Nov-2016 6.00 Interim
4 09-Mar-2016 To Be Announced 8.00 Interim
5 08-May-2015 25-Jun-2015 6.00 Final
6 05-May-2014 24-Jul-2014 10.00 Final
7 30-Apr-2013 18-Jul-2013 6.25 Final
8 26-Apr-2012 28-Jun-2012 7.50 Final
9 30-Apr-2011 23-Jun-2011 5.00 Final
10 06-May-2010 29-Jun-2010 3.50 Final
 

PROMOTER SHAREHOLDING

Look up all relevant information on shareholding pattern of AJANTPHARM, the change in shareholding as compared to last quarter, Promoters shareholding%, persons holding more than 1% shares of the company.

Shareholding PatternJun-19Mar-19Dec-18Sep-18Jun-18
Promoter and Promoter Group (%)70.5270.5270.4770.4770.48
Indian70.5270.5270.4770.4770.48
ForeignNILNILNILNILNIL
Institutions (%)19.8819.7419.7319.3218.82
FII9.459.7810.1310.9210.52
DII10.439.979.598.408.31
NonInstitutions (%)9.609.749.8010.2110.70
Bodies CorporateNILNILNILNILNIL
Others9.609.749.8010.2110.70
CustodiansNILNILNILNILNIL
Total no. of shares (cr.)8.738.738.808.808.80
 

PUBLIC SHAREHOLDING

Study of the shareholding pattern of a company is a very important part of fundamental analysis. The shareholding pattern is a determinant of the market capitalization of the stock and is an indicator of whether the stock valuation is justified or not. Know the Public shareholding % for the last quarter as announced by the company.

Persons holding securities more than 1% of total number of shares under category Public Shareholding.CategoryDec-16Sep-16Jun-16Mar-16Mar-17
Rajesh M Agrawal, trustee Rajesh Agrawal TrustPromotersNILNILNILNIL14.49
Yogesh M Agrawal, trustee Yogesh Agrawal TrustPromotersNILNILNILNIL14.49
Aayush M Agrawal, trustee Aayush Agrawal TrustPromotersNILNILNILNIL14.39
Ravi P Agrawal, trustee Ravi Agrawal TrustPromotersNILNILNILNIL14.39
Gabs investments Private limitedPromotersNILNILNILNIL9.54
Ganga Exports represented by Yogesh Agrawal, Rajesh Agrawal, Ravi Agrawal and Aayush AgrawalPromoters5.84NILNILNIL5.84
Matthews India FundNonPromoters2.532.60NILNIL2.53
Motilal Oswal Most Focused Multicap 35 FundNonPromoters1.171.311.161.191.26
Kotak Mahindra (International) LimitedNonPromoters1.101.10NIL1.101.10
Rajesh M AgrawalPromoters13.0711.53NILNILNIL
Yogesh M AgrawalPromoters13.0711.537.25NILNIL
Ravi P AgrawalPromoters11.5311.53NILNILNIL
Aayush M AgrawalPromoters11.53NILNILNILNIL
Gabs investments private limitedPromoters9.54NILNILNILNIL
Purushottam B AgrawalPromoters3.073.076.12NILNIL
Mannalal B AgrawalPromoters3.076.146.14NILNIL
Madhusudan B AgrawalPromoters3.073.07NILNILNIL
Aayush AgrawalPromotersNIL11.53NILNILNIL
Gabs Investments Pvt LtdPromotersNIL9.54NILNILNIL
Ganga Exports represented by its partners Yogesh Agrawal, Rajesh Agrawal, Ravi Agrawal and Aayush APromotersNIL5.84NILNILNIL
Manisha Yogesh Agrawal, partner of Ganga ExportsPromotersNILNIL5.84NILNIL
Madhusudan B Agrawal HUFPromotersNILNIL3.49NILNIL
Ravi Purushottam AgrawalPromotersNILNIL3.14NILNIL
Manisha Yogesh AgrawalPromotersNILNIL1.911.91NIL
Smriti Rajesh AgrawalPromotersNILNIL1.881.88NIL
Vimal M AgrawalPromotersNILNIL1.251.25NIL
Yogesh M. AgrawalPromotersNILNILNIL7.25NIL
Manisha Yogesh Agrawal, Aayush M. Agrawal, Richa R. AgrawalPromotersNILNILNIL5.84NIL
Aayush Madhusudan AgrawalPromotersNILNILNIL2.93NIL
Mamta M. AgrawalPromotersNILNILNIL2.06NIL
 

COMPANY PROFILE

Study AJANTPHARM management, company profile, ownership, management, Board of Directors and Organization Structure of AJANTPHARM

COMPANY PROFILE OF FUTURE AJANTA PHARMA, NSE, INDIA
Date of Incorporation 31-Dec-1979
Date of Listing 05-Jun-2000
Management
NameDesignation
Mannalal B Agrawal Chairman
Prabhakar Dalal Director
Anil Kumar Director
K H Viswanathan Director
Chandrakant M Khetan Director
Anjana Grewal Director
Rajesh M Agrawal Joint Managing Director
Yogesh M Agrawal Managing Director
Madhusudan B Agrawal Vice Chairman
Purushottam B Agrawal Vice Chairman
Registered Office Address
"Ajanta House",Charkop,Kandivli (West),, 400067, Mumbai, Maharashtra, India,
Website
http://www.ajantapharma.com
 

PEERS PRICE COMPARISION

# Company Name Open High Low Last Price Prv Price Change % Chng
1 AJANTA PHARMA 1206.70 1215.10 1192.00 1198.35 1198.35 0 0.00
2 NATCO PHARMA 995.95 995.95 983.00 986.70 986.70 0 0.00
3 ALKEM LABORATORIES 1841.00 1843.00 1821.00 1825.00 1825.00 0 0.00
4 SUVEN 222.05 230.40 218.10 221.15 221.15 0 0.00
5 GLAXO PHARMA 2464.00 2474.00 2436.30 2451.80 2451.80 0 0.00
6 VENUS REMEDIES 104.05 104.15 103.00 103.50 103.50 0 0.00
7 JUBILANT 657.60 662.85 641.60 643.70 643.70 0 0.00
8 PIRAMAL ENTERPRISES 2746.00 2774.90 2725.25 2761.50 2761.50 0 0.00
9 BLISS GVS 175.00 178.90 168.60 176.85 176.85 0 0.00
10 MARKSANS PHARMA 45.50 46.20 44.75 45.25 45.25 0 0.00
11 SHILPA MEDICARE 659.50 663.90 645.25 656.85 656.85 0 0.00
12 PROCTER GAMBLE HEALTH 1015.50 1072.00 1015.50 1064.30 1064.30 0 0.00
13 IPCA 500.00 503.45 493.00 495.55 495.55 0 0.00
14 OPTO CIRCUITS 6.95 7.00 6.90 6.95 6.95 0 0.00
15 ALEMBIC PHARMA 500.00 501.70 497.00 500.30 500.30 0 0.00
16 SYNGENE 495.10 503.65 491.00 493.95 493.95 0 0.00
17 KOPRAN 71.30 72.00 70.50 70.90 70.90 0 0.00
18 RPG LIFE 387.55 405.00 387.55 396.80 396.80 0 0.00
19 CAPLIN POINT 700.40 707.50 690.20 697.90 697.90 0 0.00
20 NECTAR LIFESCIENCES 27.65 27.65 26.95 27.20 27.20 0 0.00
21 SPARC 370.40 374.80 365.50 367.85 367.85 0 0.00
22 FDC 183.10 188.10 183.10 186.75 186.75 0 0.00
23 JB CHEMICALS 280.25 283.15 275.00 275.90 275.90 0 0.00
24 PFIZER 1728.80 1730.05 1711.00 1717.15 1717.15 0 0.00
25 BROOKS LAB 107.00 112.50 107.00 108.80 108.80 0 0.00
26 VIMTA LABS 128.40 130.40 128.40 129.00 129.00 0 0.00
27 MOREPEN LAB 16.75 17.00 16.50 16.60 16.60 0 0.00
28 SANOFI INDIA 4208.95 4230.00 4200.00 4213.30 4213.30 0 0.00
29 DISHMAN 288.20 304.20 278.00 301.20 301.20 0 0.00

CIN: U67190WB2003PTC096617. Trading in Commodities is done through our Group Company Dynamic Commodities Pvt. Ltd. The company is also engaged in Proprietory Trading apart from Client Business.
“2019 © COPYRIGHT DYNAMIC EQUITIES PVT. LTD.”

Disclaimer: There is no guarantee of profits or no exceptions from losses. The investment advice provided are solely the personal views of the research team. You are advised to rely on your own judgment while making investment / Trading decisions. Past performance is not an indicator of future returns. Investment is subject to market risks. You should read and understand the Risk Disclosure Documents before trading/Investing.

Disclosure: We, Dynamic Equities Private Limited are also engaged in Proprietory Trading apart from Client Business. In case of any complaints/grievances, clients may write to us at compliance@dynamiclevels.com

  • Download our Mobile App
  • Available on Google Play
  • Available on App Store
  • RSS